Accès ouvert
2024
conference-abstract
OpenAlex
Anders L. Carlson, Timothy E. Graham, Halis Kaan Aktürk, David R. Liljenquist et autres
Background: Control-IQ technology version 1.5 allows for a wider range of weight and total daily insulin (TDI) entry, in addition to other changes to enhance performance for users with high basal rates. This study evaluated the safety and performance of the updated …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Kellee M. Miller, Colleen E. Bauza, Lauren G. Kanapka, Mark Allen Clements et autres
Objective. To further evaluate glycemic outcomes during the observational extension phase of the Continuous Glucose Monitoring (CGM) Intervention for Teens and Young Adults randomized clinical trial (RCT). Subjects and Methods. Following a 26-week RCT comparing CGM with blood glucose monitoring (BGM) in …
us
(code pays fourni par la source)
2022
article
OpenAlex
Laura M. Jacobsen, Laura E. Bocchino, John W. Lum, Craig Kollman et autres
Background: The COVID-19 pandemic and the rapid expansion of telemedicine have increased the need for accurate and reliable capillary hemoglobin A1c (HbA1c) testing. Nevertheless, validation studies of commercially available products suitable for home use have been in short supply. Methods: Three commercial …
us
(code pays fourni par la source)
2021
article
OpenAlex
Roy W. Beck, Laura E. Bocchino, John W. Lum, Craig Kollman et autres
Background: The COVID-19 pandemic has impacted the conduct of clinic visits. We conducted a study to evaluate two academic laboratories' fingerstick capillary blood collection kits suitable for home use for laboratory measurement of HbA1c. Methods: Four clinical sites recruited 240 participants (aged …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Kara Mizokami Stout, Zoey Li, Nicole C. Foster, Viral N. Shah et autres
OBJECTIVE To evaluate the contemporary prevalence of diabetic peripheral neuropathy (DPN) in participants with type 1 diabetes in the T1D Exchange Clinic Registry throughout the U.S. RESEARCH DESIGN AND METHODS DPN was assessed with the Michigan Neuropathy Screening Instrument Questionnaire (MNSIQ) in …
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Kellee M. Miller, Julia M. Hermann, Nicole C. Foster, Sabine E. Hofer et autres
Continuous glucose monitoring (CGM) has been demonstrated in randomized trials to improve glucose control in patients with type 1 diabetes (1), but until recently only a minority of participants in the German/Austrian Diabetes Patienten Verlaufsdokumentation (DPV) registry and the U.S.-based T1D Exchange …
us, de, at
(code pays fourni par la source)
2015
article
OpenAlex
Stephanie N. DuBose, Julia M. Hermann, William V. Tamborlane, Roy W. Beck et autres
us, de, au, at
(code pays fourni par la source)